Latest Breaking News On - Bharath kumar tirupakuzhi vijayaraghavan - Page 1 : comparemela.com

Regional variations uncovered in the impact of dexamethasone treatment for severe COVID-19

Regional variations uncovered in the impact of dexamethasone treatment for severe COVID-19
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Tamil naduBharath kumar tirupakuzhi vijayaraghavanGeorge institute for global health indiaLancet regional healthGeorge institute for global healthGeorge instituteGlobal healthSoutheast asiaGlobal health indiaApollo hospitalAdverse reactionsAlive without life supportRelated quality

Dexamethasone treatment had minimal impact in India but led to lower mortality risk in Europe: Lancet study

European patients gained more days without life support with the higher dose, whereas Indian patients saw minimal difference

Tamil naduBharath kumar tirupakuzhi vijayaraghavanLancet regional healthGeorge institute for global health indiaSoutheast asiaGeorge instituteGlobal health indiaApollo hospitalHealth related qualityDexamethasone treatmentMortality riskOrtality risk in europeLower mortality rate

Intravenous Vitamin C for Patients Hospitalized With COVID-19

Two randomized clinical trials were harmonized to compare the effect of vitamin C vs control on outcomes in hospitalized patients with COVID-19 who were critica

United statesNew delhiSaudi arabiaKrung thep mahanakhonWestern australiaCity ofUnited kingdomNational universitySan franciscoSouth australiaNew zealandNorthern irelandFrance generalWellington hillsNorthern territoryAr riya

One in two patients across ICUs in India suffers from sepsis, reveals new Sepsis in India Prevalence Study

The study by The George Institute researchers, though by no means exhaustive, is indicative of alarming trends India has a high burden of sepsis with

New south walesTamil naduBharath kumarBharath kumar tirupakuzhi vijayaraghavanVivekanand jhaNaomi hammondBala venkateshAshwani kumarCritical care programGeorge instituteGeorge institute for global healthSepsis prevalenceAdult patientsExecutive directorHonorary senior fellowGlobal health

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial | Critical Care Medicine | JAMA

This multicenter randomized clinical trial compares the effects of 12 mg/d vs 6 mg/d of dexamethasone in patients with COVID-19 and severe hypoxemia.

Denmark generalNew delhiCity ofUnited kingdomNew south walesTamil naduAbhinav bassiMehuls shahSarah weiheAnubhuti jhaAjay padmanabanAlisonh pindAnton berggrenAdam heymowskiKarolinska institutetKlausv marcussen